Dermisonics' U-Strip gets Sontra riled
This article was originally published in Clinica
Executive Summary
Franklin, Massachusetts-based transdermal drug delivery company Sontra has sent a notice to Dermisonics alleging that its U-Strip system, which is still in the early stages of clinical trials, infringes two patents relating to Sontra's SonoPrep technology. Dermisonics has disputed Sontra's allegations and is investigating its claims.